DNA repair: from genome maintenance to biomarker and therapeutic target.
about
The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cellsInter-individual variation in DNA repair capacity: a need for multi-pathway functional assays to promote translational DNA repair researchLinking DNA adduct formation and human cancer risk in chemical carcinogenesis.Multiplexed DNA repair assays for multiple lesions and multiple doses via transcription inhibition and transcriptional mutagenesis.Inactivation of DNA-dependent protein kinase promotes heat-induced apoptosis independently of heat-shock protein induction in human cancer cell lines.Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variantsPolymorphisms of the XPC gene may contribute to the risk of head and neck cancer: a meta-analysis.DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity.The diverse and complex roles of radiation on cancer treatment: therapeutic target and genome maintenance.Human CST abundance determines recovery from diverse forms of DNA damage and replication stress.Smad4 loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitors.Gastroesophageal junction adenocarcinoma displays abnormalities in homologous recombination and nucleotide excision repair.Nucleotide excision repair of 2-acetylaminofluorene- and 2-aminofluorene-(C8)-guanine adducts: molecular dynamics simulations elucidate how lesion structure and base sequence context impact repair efficienciesChemotherapy induced DNA damage response: convergence of drugs and pathwaysMultiple gene sequencing for risk assessment in patients with early-onset or familial breast cancerSerum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patientsThe potential of exploiting DNA-repair defects for optimizing lung cancer treatment.Small-molecule inhibitors of DNA damage-repair pathways: an approach to overcome tumor resistance to alkylating anticancer drugs.Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma.Effects on DNA Damage and/or Repair Processes as Biological Mechanisms Linking Psychological Stress to Cancer RiskXRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population.Pharmacogenomics of platinum-based chemotherapy in non-small cell lung cancer: focusing on DNA repair systems.Quantitative measurement of alterations in DNA damage repair (DDR) pathways using single cell network profiling (SCNP)Base damage, local sequence context and TP53 mutation hotspots: a molecular dynamics study of benzo[a]pyrene induced DNA distortion and mutabilityExpression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial CarcinomaSatellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1.Long non-coding RNAs associated with non-small cell lung cancer.In vivo measurements of interindividual differences in DNA glycosylases and APE1 activities.Polymorphisms in 2 and 5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review
P2860
Q27340125-C15F88B4-B62D-42CA-A4E8-A6E0FF311830Q28388726-0FAFDE99-8127-4F4F-8C6E-99487077C70CQ30249312-B4BB23E8-C829-4C7D-8607-110F4DD50682Q33606811-5F0462E6-2557-4949-A206-459F64FE666AQ34625724-0FDC387B-BAC4-4BCB-933F-39FDA1F8B548Q34700954-907199B9-C5C7-4BD7-903F-026A0F3A0731Q35066932-D3A2E656-1075-4E90-A074-1178DF2502BEQ36073749-B357E1FC-80B9-41E5-9E61-DC0AA56C609BQ36135801-9410B07D-29FE-468D-8876-B3149A94A071Q36182484-CE81BC8B-FECF-4EA1-BD27-DB6B7A85C5DAQ36189638-0E9F99CD-AC80-4375-9825-68978BC2B062Q36283677-B61F1B73-75DA-432B-8A68-ABD232D50AE5Q36341580-388016FC-4CF1-42FB-9AAD-51BA7A6A5044Q36901484-945CA3FC-27B8-4ED8-9702-5D9B2812C11CQ36946787-A8125164-CE2C-4255-A2AF-9D6E8D3D17B6Q37684604-F9478F1B-8DDE-4590-AF68-F4A3B5A2BCC2Q37983690-41D5330C-877E-4969-B428-7576DE506D18Q38019607-F49DB0AC-18C9-4003-9C60-775753027AFBQ38066230-3E657DD0-B794-4754-9B11-822AC0074C46Q38217219-4D1EB2FB-CCF5-4187-B472-C74D1FDAEA92Q38407822-5ED1BA83-7C71-46AF-8D0E-70E29E1E0FB1Q38953629-5C5C2DB8-F410-44C1-8B65-98103601A75FQ38981220-78C1A15A-35FC-4C2F-A82F-627F3A7C87B8Q40509000-DA3135D8-C6AE-449A-9D7F-F88C78E5465CQ41002840-32B8EDEB-8CBE-4770-9EF6-ED08C82AF253Q41345087-F810E46C-9F05-4433-A3CD-732B45B58368Q42366666-B0DB3F0D-1D4D-407B-9C61-BCBB0E281C43Q47363972-3306DAE9-31F5-4B47-9EDE-7C2635F99131Q57109501-9F0FA82B-5529-41D4-A7B8-EF9BB69BAA0C
P2860
DNA repair: from genome maintenance to biomarker and therapeutic target.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
DNA repair: from genome maintenance to biomarker and therapeutic target.
@ast
DNA repair: from genome maintenance to biomarker and therapeutic target.
@en
type
label
DNA repair: from genome maintenance to biomarker and therapeutic target.
@ast
DNA repair: from genome maintenance to biomarker and therapeutic target.
@en
prefLabel
DNA repair: from genome maintenance to biomarker and therapeutic target.
@ast
DNA repair: from genome maintenance to biomarker and therapeutic target.
@en
P2093
P2860
P1476
DNA repair: from genome maintenance to biomarker and therapeutic target.
@en
P2093
Jennifer N Earley
John J Turchi
Shadia Jalal
P2860
P304
P356
10.1158/1078-0432.CCR-11-0761
P407
P577
2011-09-09T00:00:00Z